Catalyst Calendar

Mon, Sep 28, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Mon, Sep 14, 2026

2 updates

DFTX

7:00 AM

Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder

Trial Results • Phase 3Topline results release Mon, Sep 14, 2026, 7:00 AM EDTdefiniumtx.com

DFTX

6:00 AM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Sun, Sep 13, 2026

1 updates

DFTX

5:00 PM

Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026

Results Call • Phase 3Results call Mon, Sep 14, 2026, 8:00 AM EDTdefiniumtx.com

Thu, Sep 10, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026

Presentation / Abstract • Phase 3Psych Congress oral presentation Thu, Sep 17, 2026, 9:00 AM CDTdefiniumtx.com

Tue, Sep 8, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results

definiumtx.com

Mon, Aug 31, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Wed, Aug 26, 2026

1 updates

DFTX

7:01 AM

Definium Therapeutics to Participate at Upcoming Investor Conferences and Events

Results Call • Phase 3Results call Tue, Sep 1, 2026, 1:00 PM ETdefiniumtx.com

Mon, Aug 17, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Wed, Aug 12, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder

Trial Results • Phase 3Topline results release Wed, Aug 12, 2026, 7:00 AM EDTdefiniumtx.com

Thu, Aug 6, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Trial Results • Phase 3Results event Mon, Jun 30, 2025, 4:30 PM EDTdefiniumtx.com

Mon, Aug 3, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, Jul 30, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

definiumtx.com

Mon, Jul 20, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, Jul 16, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology

definiumtx.com

Tue, Jul 14, 2026

1 updates

DFTX

7:00 AM

New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)

definiumtx.com